Evidence map›Paper›PMID 35502167›Full record

ArticleJournal of manufacturing systems2022

Workforce planning and production scheduling in a reconfigurable manufacturing system facing the COVID-19 pandemic.

Behdin Vahedi-Nouri, Reza Tavakkoli-Moghaddam, Zdeněk Hanzálek, Alexandre Dolgui

Abstract read
In one paragraph

Article in Journal of manufacturing systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Behdin Vahedi-NouriSchool of Industrial Engineering, College of Engineering, University of Tehran, Tehran, Iran.
Reza Tavakkoli-MoghaddamSchool of Industrial Engineering, College of Engineering, University of Tehran, Tehran, Iran.
Zdeněk HanzálekIID-CIIRC, Czech Technical University in Prague, Czech Republic.
Alexandre DolguiIMT Atlantique, LS2N - CNRS, La Chantrerie, Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the outbreak of the COVID-19 pandemic, the manufacturing sector has been experiencing unprecedented issues, including severe fluctuation in demand, restrictions on the availability and utilization of the workforce, and governmental regulations. Adopting conventional manufacturing practices and planning approaches under such circumstances cannot be effective and may jeopardize workers' health and satisfaction, as well as the continuity of businesses. Reconfigurable Manufacturing System (RMS) as a new manufacturing paradigm has demonstrated a promising performance when facing abrupt market or system changes. This paper investigates a joint workforce planning and production scheduling problem during the COVID-19 pandemic by leveraging the adaptability and flexibility of an RMS. In this regard, workers' COVID-19 health risk arising from their allocation, and workers' preferences for flexible working hours are incorporated into the problem. Accordingly, first, novel Mixed-Integer Linear Programming (MILP) and Constraint Programming (CP) models are developed to formulate the problem. Next, exploiting the problem's intrinsic characteristics, two properties of an optimal solution are identified. By incorporating these properties, the initial MILP and CP models are considerably improved. Afterward, to benefit from the strengths of both improved models, a novel hybrid MILP-CP solution approach is devised. Finally, comprehensive computational experiments are conducted to evaluate the performance of the proposed models and extract useful managerial insights on the system flexibility.

Indexed as

Constraint programmingCOVID-19 pandemicReconfigurable machine toolReconfigurable manufacturing systemSchedulingWorkforce planning

Identifiers

PMID35502167
PMCPMC9046071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.